What is Giving Compass?
We connect donors to learning resources and ways to support community-led solutions. Learn more about us.
Giving Compass' Take:
• A $100 million antiretroviral (ARV) factory is set to open later this year in Kenya in an effort to stop the HIV epidemic in Africa.
• Kenya has the fourth largest HIV epidemic in the world with 53,000 new infections and 28,000 AIDS-related deaths annually. How can this new factory ensure it's success in combating this disease?
• Learn about what it will take to end AIDS within ten years.
Kenya is set to change how HIV/AIDS medication is distributed around the country and in Africa, when a $100 million antiretroviral (ARV) factory opens later this year.
At the moment, the country imports most of its treatment from Europe. The factory — which is will be largest of its kind on the continent — is a partnership between the government, local pharmaceutical manufacturers, and the Global Fund to Fight AIDS, Tuberculosis (TB), and Malaria.
Most of the ARVs will be under patent from European parent companies. This will reduce the amount Kenya spends on importing ARVs — mostly from Europe — and create an estimated 1,000 jobs.
Read the full article on Kenya's antiretrovial factory by Lerato Mogoatlhe at Global Citizen.